Hitoshi Mochizuki

3.7k total citations
109 papers, 1.7k citations indexed

About

Hitoshi Mochizuki is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Hitoshi Mochizuki has authored 109 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Cancer Research, 35 papers in Pulmonary and Respiratory Medicine and 34 papers in Oncology. Recurrent topics in Hitoshi Mochizuki's work include Cancer Genomics and Diagnostics (35 papers), Lung Cancer Treatments and Mutations (20 papers) and Pancreatic and Hepatic Oncology Research (16 papers). Hitoshi Mochizuki is often cited by papers focused on Cancer Genomics and Diagnostics (35 papers), Lung Cancer Treatments and Mutations (20 papers) and Pancreatic and Hepatic Oncology Research (16 papers). Hitoshi Mochizuki collaborates with scholars based in Japan, United States and Canada. Hitoshi Mochizuki's co-authors include Masao Omata, Yosuke Hirotsu, Kenji Amemiya, Toshio Oyama, Taichiro Goto, Hiroshi Nakagomi, Yoshihiro Miyashita, Toshiharu Tsutsui, Yumiko Kakizaki and Yuki Nagakubo and has published in prestigious journals such as PLoS ONE, Cancer and Scientific Reports.

In The Last Decade

Hitoshi Mochizuki

102 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hitoshi Mochizuki Japan 24 481 471 446 416 386 109 1.7k
Kenji Amemiya Japan 24 539 1.1× 483 1.0× 459 1.0× 360 0.9× 319 0.8× 98 1.6k
Sven Peine Germany 26 535 1.1× 398 0.8× 665 1.5× 643 1.5× 245 0.6× 82 2.3k
Samuel Murray Greece 24 652 1.4× 1.1k 2.4× 1.3k 2.9× 778 1.9× 268 0.7× 50 2.5k
Ge Ma China 24 480 1.0× 216 0.5× 902 2.0× 837 2.0× 57 0.1× 53 2.6k
Jon Glass United States 27 227 0.5× 571 1.2× 244 0.5× 382 0.9× 248 0.6× 68 2.8k
Travis K. Hughes United States 14 387 0.8× 159 0.3× 244 0.5× 1.1k 2.7× 94 0.2× 21 2.3k
Tracy L. Bergemann United States 21 114 0.2× 303 0.6× 447 1.0× 730 1.8× 186 0.5× 36 2.4k
Michele Ardolino Canada 17 193 0.4× 157 0.3× 1.4k 3.2× 481 1.2× 120 0.3× 31 2.7k
George Santis United Kingdom 26 150 0.3× 832 1.8× 491 1.1× 699 1.7× 312 0.8× 60 2.0k
Jonathan H. Esensten United States 16 151 0.3× 97 0.2× 678 1.5× 437 1.1× 181 0.5× 21 2.3k

Countries citing papers authored by Hitoshi Mochizuki

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Mochizuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Mochizuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Mochizuki more than expected).

Fields of papers citing papers by Hitoshi Mochizuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Mochizuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Mochizuki. The network helps show where Hitoshi Mochizuki may publish in the future.

Co-authorship network of co-authors of Hitoshi Mochizuki

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Mochizuki. A scholar is included among the top collaborators of Hitoshi Mochizuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Mochizuki. Hitoshi Mochizuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amemiya, Kenji, Yosuke Hirotsu, Yuji Iimuro, et al.. (2025). Decoding Genomic Diversity to Guide Tumor Lesion‐Specific Treatment of Multifocal Hepatocellular Carcinoma. Cancer Medicine. 14(7). e70814–e70814. 1 indexed citations
2.
Ohyama, Hiroshi, Yosuke Hirotsu, Kenji Amemiya, et al.. (2024). Liquid biopsy of wash samples obtained via endoscopic ultrasound‐guided fine‐needle biopsy: Comparison with liquid biopsy of plasma in pancreatic cancer. Diagnostic Cytopathology. 52(6). 325–331. 1 indexed citations
3.
Ohyama, Hiroshi, Rintaro Mikata, Yosuke Hirotsu, et al.. (2024). The efficacy of bile liquid biopsy in the diagnosis and treatment of biliary tract cancer. Journal of Hepato-Biliary-Pancreatic Sciences. 31(5). 329–338. 4 indexed citations
4.
Nagakubo, Yuki, Yosuke Hirotsu, Kenji Amemiya, et al.. (2023). Nucleic Acid Quality Assessment is Critical to the Success of the Oncomine Dx Target Test for Lung Cancer. Molecular Diagnosis & Therapy. 27(4). 513–523. 6 indexed citations
5.
Ohyama, Hiroshi, Yosuke Hirotsu, Kenji Amemiya, et al.. (2023). Development of a molecular barcode detection system for pancreaticobiliary malignancies and comparison with next-generation sequencing. Cancer Genetics. 280-281. 6–12. 18 indexed citations
6.
Amemiya, Kenji, Yosuke Hirotsu, Hitoshi Mochizuki, et al.. (2022). Deep targeted sequencing of cytological tumor cells using whole genome amplification. Cancer Cytopathology. 131(1). 58–68. 3 indexed citations
7.
Ohyama, Hiroshi, Yosuke Hirotsu, Kenji Amemiya, et al.. (2022). Detection of actionable mutations in cytological specimens obtained by endoscopic ultrasound-guided fine needle aspiration with rapid onsite evaluation in pancreatic cancer. Annals of Diagnostic Pathology. 60. 152008–152008. 4 indexed citations
8.
Nagakubo, Yuki, Yosuke Hirotsu, Makoto Maejima, et al.. (2022). Non-pharmaceutical interventions during the COVID-19 epidemic changed detection rates of other circulating respiratory pathogens in Japan. PLoS ONE. 17(1). e0262874–e0262874. 9 indexed citations
9.
Higuchi, Rumi, Taichiro Goto, Yosuke Hirotsu, et al.. (2021). Streptococcus australis and Ralstonia pickettii as Major Microbiota in Mesotheliomas. Journal of Personalized Medicine. 11(4). 297–297. 16 indexed citations
10.
Higuchi, Rumi, Taichiro Goto, Yosuke Hirotsu, et al.. (2021). Sphingomonas and Phenylobacterium as Major Microbiota in Thymic Epithelial Tumors. Journal of Personalized Medicine. 11(11). 1092–1092. 14 indexed citations
11.
Hirotsu, Yosuke, Hiroki Sugiura, Makoto Maejima, et al.. (2021). Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19. International Journal of Infectious Diseases. 108. 263–269. 14 indexed citations
12.
Hirotsu, Yosuke, Makoto Maejima, Masahiro Shibusawa, et al.. (2020). Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection. Journal of Infection and Chemotherapy. 27(2). 406–409. 31 indexed citations
13.
Hirotsu, Yosuke, Hitoshi Yokoyama, Kenji Amemiya, et al.. (2020). Genomic Profiling Identified ERCC2 E606Q Mutation in Helicase Domain Respond to Platinum-Based Neoadjuvant Therapy in Urothelial Bladder Cancer. Frontiers in Oncology. 10. 1643–1643. 8 indexed citations
14.
Hirotsu, Yosuke, Makoto Maejima, Masahiro Shibusawa, et al.. (2020). Analysis of Covid-19 and non-Covid-19 viruses, including influenza viruses, to determine the influence of intensive preventive measures in Japan. Journal of Clinical Virology. 129. 104543–104543. 43 indexed citations
15.
Hirotsu, Yosuke, Sotaro Otake, Hiroshi Ohyama, et al.. (2020). Dual-molecular barcode sequencing detects rare variants in tumor and cell free DNA in plasma. Scientific Reports. 10(1). 3391–3391. 26 indexed citations
16.
Nakagomi, Takahiro, Yosuke Hirotsu, Taichiro Goto, et al.. (2019). Clinical Implications of Noncoding Indels in the Surfactant-Encoding Genes in Lung Cancer. Cancers. 11(4). 552–552. 10 indexed citations
17.
Nagakubo, Yuki, Yosuke Hirotsu, Kenji Amemiya, et al.. (2019). Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR. BMC Medical Genomics. 12(1). 162–162. 15 indexed citations
18.
Hirotsu, Yosuke, Yuki Nagakubo, Kenji Amemiya, et al.. (2019). Microsatellite instability status is determined by targeted sequencing with MSIcall in 25 cancer types. Clinica Chimica Acta. 502. 207–213. 16 indexed citations
19.
Goto, Taichiro, Yosuke Hirotsu, Kenji Amemiya, Hitoshi Mochizuki, & Masao Omata. (2018). Understanding Intratumor Heterogeneity and Evolution in NSCLC and Potential New Therapeutic Approach. Cancers. 10(7). 212–212. 19 indexed citations
20.
Amemiya, Kenji, Yosuke Hirotsu, Taichiro Goto, et al.. (2016). Touch imprint cytology with massively parallel sequencing (TIC‐seq): a simple and rapid method to snapshot genetic alterations in tumors. Cancer Medicine. 5(12). 3426–3436. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenji Amemiya Breakdown of academic impact, for papers by Sven Peine Breakdown of academic impact, for papers by Samuel Murray Breakdown of academic impact, for papers by Ge Ma Breakdown of academic impact, for papers by Jon Glass Breakdown of academic impact, for papers by Travis K. Hughes Breakdown of academic impact, for papers by Tracy L. Bergemann Breakdown of academic impact, for papers by Michele Ardolino Breakdown of academic impact, for papers by George Santis Breakdown of academic impact, for papers by Jonathan H. Esensten
Rankless by CCL
2026